Rapid UTI Diagnostics
Point-of-Care Molecular UTI Testing
A point-of-care molecular analyser for urinary tract infections.
35 minutes
from sample to answer
Current Practice
Most UTI antibiotics are prescribed before the pathogen is known.
Laboratory urine culture takes 48–72 hours. Antibiotic decisions are typically made empirically before results arrive.
Pre-operative bacteriuria can delay or cancel urological procedures.
Empirical prescribing limits antimicrobial stewardship.
Lodestar DX
Pathogen identification, in 35 minutes.
The Lodestar UTI testing system is a UKCA-marked point-of-care molecular analyser for the identification of common uropathogens. From a 10 µL urine sample, the device identifies one or more of six target pathogens in 35 minutes — informing the prescribing decision before the patient receives treatment.
Clinical Evidence
Performance demonstrated in an 846 patient samples evaluation.
86%
sensitivity
overall, n=846
84%
specificity
overall, n=846
92%
NPV
pre-operative screening, n=189
Pre-operative use
Rapid rule-out before urological procedures.
Asymptomatic bacteriuria before urological surgery currently relies on either empirical treatment or a culture wait that delays the procedure. The Lodestar UTI testing system delivers a 35-minute pathogen result at the point of pre-operative urology screening — informing targeted antibiotic selection where bacteriuria is present, and reducing the number of cancelled procedures.
Change the way you manage UTIs.
For clinical evaluation enquiries, pre-op pathway discussions, or commercial conversations, book a meeting with the Syner-Med team.